Uncategorized
Triple therapy outperforms double therapy in treatment of PCV
Triple therapy comprising photodynamic therapy, intravitreal bevacizumab and subtenon triamcinolone acetonide injections markedly improved vision in eyes with treatment-naïve subfoveal polypoidal choroidal vasculopathy, according to study findings.The retrospective, comparative, interventional case series included 36 eyes of 36 patients with treatment-naïve subfoveal polypoidal choroidal vasculopathy. Seventeen patients underwent PDT combined with intravitreal Avastin (bevacizumab, Genentech), and 19 patients underwent PDT, intravitreal bevacizumab and subtenon triamcinolone acetonide (STTA) injections. All patients underwent slit lamp biomicroscopy, fundus imaging, fluorescein angiography and optical coherence tomography.